RecruitingNCT06181994

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Outcomes of Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma; Middle Meningeal Artery Embolization for Chronic Subdural Hematoma (MESH)

Sponsor

Montefiore Medical Center

Enrollment

5,000 participants

Start Date

Dec 5, 2023

Study Type

OBSERVATIONAL

Conditions

Chronic Subdural Hematoma

Summary

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with chronic subdural hematoma. The study is currently recruiting participants at 19 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(19)

Baptist Health South Florida, Inc.

Coral Gables, Florida, United States

Mayo Clinic Florida

Jacksonville, Florida, United States

Orlando Regional Medical Center

Orlando, Florida, United States

University of Illinois Chicago

Chicago, Illinois, United States

University of Chicago Medicine

Chicago, Illinois, United States

The University of Iowa

Iowa City, Iowa, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School

Boston, Massachusetts, United States

Lahey Hospital and Medical Center

Burlington, Massachusetts, United States

Mayo Clinic

Rochester, Minnesota, United States

Montefiore Medical Center

The Bronx, New York, United States

Geisinger Health

Danville, Pennsylvania, United States

Thomas Jefferson University

Philadelphia, Pennsylvania, United States

UTHealth Houston

Houston, Texas, United States

HCA Houston Healthcare Kingwood

Kingwood, Texas, United States

Austin Health

Heidelberg, Victoria, Australia

Unity Health Toronto

Toronto, Ontario, Canada

University of Toronto

Toronto, Ontario, Canada

Toronto Western Hospital

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06181994

Related Trials

Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)

NCT072452641 location

Middle Meningeal Artery Embolization for Patients With Chronic Subdural Hematoma

NCT067727401 location

Assessing Outcomes of Coil Embolization for Unilateral vs Bilateral Chronic Subdural Hematomas

NCT077156561 location

Efficacy of a Minimally Invasive Therapy Adjuvant to the Standards of Care by Cyanoacrylate Embolization

NCT0537468111 locations

Non-Thermal Plasma to Reduce Recurrence in Chronic Subdural Hematoma

NCT076568181 location